Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratório Daudt, founded in 1882, is the oldest pharmaceutical company in Brazil and a pioneer in the country's healthcare industry. Headquartered in Rio de Janeiro, the company specializes in the development and manufacturing of over-the-counter (OTC) and prescription medications, as well as cosmetics and functional foods. Its portfolio includes iconic Brazilian brands such as Malvatricin, Bismu-Jet, and Dersani, focusing on therapeutic areas like oral health, dermatology, and respiratory care. In 2016, Laboratório Daudt was acquired by Megalabs, a leading Latin American pharmaceutical group, which has integrated Daudt's traditional expertise with modern regional distribution and R&D capabilities. Today, it continues to operate as a key subsidiary within the Megalabs Brazil structure, maintaining its legacy of providing accessible therapeutic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratório Daudt.